Skip to content
The Nexus
DossierENTITY

Peptide Industry

Coverage of Peptide Industry in the Nexus archive.

Earliest in view: Apr 19 · 14:43 UTCMost recent: Jul 24 · 10:05 UTC
Co-mentioned in this coverage
FDAorganization1Robert F. Kennedy Jr.person1BPC-157topic1TB-500topic1epitalontopic1Telehealth companiesorganization1San Franciscoplace1Peptide Researchtopic1Hacker Newsorganization112 Grams of Carbonorganization1
Recent coverage
  • HEALTHJul 24 · 10:05 UTCBUSINESS INSIDER
    Inside the unconventional FDA panel that could reshape the peptide industry

    An FDA advisory panel led by Robert F. Kennedy Jr. is reviewing seven banned therapeutic peptides, including BPC-157, TB-500, and epitalon, amid concerns over safety and efficacy. The two-day meeting (July 23-24) includes panelists with ties to peptide research, sales, or prescription, marking an unconventional approach to regulatory evaluation.

  • SCIENCEApr 19 · 14:43 UTCHACKER NEWS
    Notes from the SF Peptide Scene

    The article 'Notes from the SF Peptide Scene' provides an overview of the peptide research and industry landscape in San Francisco, highlighting local advancements and community discussions. It includes links to the original blog post and Hacker News comments for further context.